Pharmaceutical intermediates
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>GLP-1 (Glucagon-like peptide-1) is a <strong>peptide hormone</strong> regulating glucose metabolism via incretin pathways. Synthesized through <strong>solid-phase peptide synthesis</strong>, its core structure mimics endogenous isoforms. Common derivatives include exenatide and liraglutide.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceuticals:</strong> Treatment of type 2 diabetes and obesity management.</li>
<li><strong>Clinical Research:</strong> Metabolic syndrome studies and cardiovascular risk assessment.</li>
<li><strong>Diagnostics:</strong> Biomarker analysis for insulin secretion capacity.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in patients with personal or family history of medullary thyroid carcinoma. Storage requires <strong>-20°C refrigeration</strong> to maintain stability. Handling demands PPE to prevent dermal exposure during manufacturing.</p>